Anavex Life Sciences Corp. (AVXL) stock
AVXLNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends September 30
$0.74−0.08 (-9.49%)
Close on Nov 17, 2026Market cap $68.60MP/E –Yield –
Anavex Life Sciences ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
For fiscal 2014 it was -$2.97M. The highest annual figure on record is -$2.14M in fiscal 2013.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2014 | Sep 30, 2014 | -$2.97M | – |
| FY2013 | Sep 30, 2013 | -$2.14M | – |
| FY2012 | Sep 30, 2012 | -$4.32M | – |
| FY2011 | Sep 30, 2011 | -$6.18M | – |
| FY2010 | Sep 30, 2010 | -$5.65M | – |
See a number that looks wrong?